Explore more publications!

Press Releases

Living with a Rare Disease: A Pastor’s Journey Finding the Right Care and Treatment for NF1-PN 
Ascendis Pharma to Participate in the TD Cowen 46th Annual Health Care Conference
ESO Wave Convenes Emergency Services and Healthcare Leaders To Advance Data-Driven Outcomes
Hospitals Electronic Health Records Turn Data Into Better Decisions, Approaching $28.94 Billion by 2035
Newsweek and Statista Announce World’s Best Hospitals 2026, Expanding Global Reach and Elevating Patient-Reported Outcomes in Evaluations
Menstrual Health Apps Market’s 20.28% CAGR Reflects Strong Investor Confidence in Women-Centric Innovation
Evaxion to announce business update and full year 2025 financial results on March 5, 2026
Alveus Therapeutics Announces Second and Final Closing of Oversubscribed Series A, Bringing Total Financing to $197 Million to Advance Next‑Generation Therapies for Obesity and Metabolic Diseases
Greenland Says “No Thank You” to Trump’s Hospital Ship Offer

Greenland Says “No Thank You” to Trump’s Hospital Ship Offer

Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology
This American Heart Month Amarin Spotlights the Need to Prioritize Proven Widely Available Yet Underutilized Therapies in the Battle Against Cardiovascular Disease
Trump Dispatches Navy Medical Ship to Greenland

Trump Dispatches Navy Medical Ship to Greenland

Greenland Declines US Proposal to Deploy Hospital Ship

Greenland Declines US Proposal to Deploy Hospital Ship

Trump Announces Deployment of Hospital Ship to Greenland

Trump Announces Deployment of Hospital Ship to Greenland

Trump Announces US Hospital Ship Deployment to Greenland

Trump Announces US Hospital Ship Deployment to Greenland

Greenland Refuses Trump’s Hospital Ship Offer

Greenland Refuses Trump’s Hospital Ship Offer

Greenland Spurns Trump's Hospital Ship Offer

Greenland Spurns Trump's Hospital Ship Offer

Clinical Trials Support Software Solutions in a $34.15B Trial Economy by 2035
Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development Milestone
Zealand Pharma Announces Financial Results for the Full Year 2025

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions